Načítá se...
Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C
AIM: To evaluate the efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. METHODS: Thirty-six hemodialysis patients with chronic hepatitis C were enrolled in a controlled and prospective study. All patients were treatment naive, positive tested for...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The WJG Press and Baishideng
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2675123/ https://ncbi.nlm.nih.gov/pubmed/18186564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.255 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|